SRI Lands $150M NIH Contract to Help Develop Candidate HIV Prevention Products

HealthSRI International has secured a seven-year, $150 million contract from the National Institutes of Health to provide development services for candidate HIV prevention products from investigator-initiated studies or from partnerships with other companies and organizations.

SRI said Tuesday its biosciences division will manufacture and characterize drug products to support the development of microbicide and non-vaccine pre-exposure agents through preclinical and clinical studies for the NIH’s National Institute of Allergy and Infectious Diseases and the Division of AIDS.

The company will also support activities that the Food and Drug Administration requires to move products into clinical tests.

Gita Shankar, an SRI director, has led a project to develop a multipurpose HIV prevention microbicide bioadhesive gel under an NIAID grant the company received in 2010.

SRI also produced drug products and supplied clinical sites with microbicides and contraceptive controls between 2000 and 2004.

You may also be interested in...

U.S. Air Force

Air Force Picks Nine Awardees for Potential $400M Skyborg UAV Prototyping Support IDIQ

Nine entities have won spots on a potential $400M contract to develop autonomous elements and support prototyping of the U.S. Air Force's Skyborg unmanned aircraft for experimental purposes.

US Army Humvee

AM General Secures $458M in Army Humvee Component Supply Contracts

AM General has landed a pair of potential five-year contracts worth $458M combined from the Defense Logistics Agency to supply parts for the U.S. Army's High Mobility Multipurpose Wheeled Vehicles.